Ubs Group Ag Exicure, Inc. Transaction History
Ubs Group Ag
- $400 Billion
- Q2 2024
A detailed history of Ubs Group Ag transactions in Exicure, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 17,311 shares of XCUR stock, worth $65,954. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,311
Previous 1,831
845.44%
Holding current value
$65,954
Previous $1,000
400.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding XCUR
# of Institutions
17Shares Held
766KCall Options Held
0Put Options Held
0-
Abingworth LLP London, X0282KShares$1.07 Million0.11% of portfolio
-
Carlyle Group Inc. Washington, DC282KShares$1.07 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA56.5KShares$215,3370.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA46KShares$175,2670.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.1KShares$152,7540.0% of portfolio
About EXICURE, INC.
- Ticker XCUR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 4,962,580
- Market Cap $18.9M
- Description
- Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie...